Strain Catalog

Showing results 101 to 200 of 7208

< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 Next >
Strain Descriptor Strain Summary Genotype Phenotype
abpC-/[act15]:abpCabpC (filamin, 120-kD gelation factor) overexpressor in abpC null mutant; derived from AX2-214, neomycin resistantaxeA2, axeB2, axeC2, gelA1000 [pPROF389] neoR
abpC-/[act15]:abpCabpC overexpressed in abpC null mutantaxeA1, axeB1, axeC1, abpC-, [p120cl], [g7PYR5Δ6.2], ura-, abpC, [pABP-120PYR], neoR
abpC-/[act15]:abpC(1-348:449-857):GFPC-terminal fusion of GFP abpC missing rod domain 2 expressed in an abpC null mutantaxeA2, axeB2, axeC2, abpC-, abpC(1-348/449-857):GFP, bsR
abpC-/[act15]:abpC(1-448):GFPC-terminal fusion of GFP abpC missing rod domains 3-6 expressed in an abpC null mutantaxeA2, axeB2, axeC2, abpC-, abpC(1-448):GFP, bsR
abpC-/[act15]:abpC(1-556):GFPC-terminal fusion of GFP abpC missing rod domains 4-6 expressed in an abpC null mutantaxeA2, axeB2, axeC2, abpC-, abpC(1-556):GFP, bsR
abpC-/[act15]:abpC(1-556:644-857):GFPC-terminal fusion of GFP abpC missing rod domain 4 expressed in an abpC null mutantaxeA2, axeB2, axeC2, abpC-, abpC(1-556/644-857):GFP, bsR
abpC-/[act15]:abpC(1-669):GFPC-terminal fusion of GFP abpC missing the 5th and 6th rod domain expressed in an abpC null mutantaxeA2, axeB2, axeC2, abpC-, abpC(1-669):GFP, bsR
abpC-/[act15]:abpC(1-739):GFPC-terminal fusion of GFP abpC missing the 6th rod domain expressed in an abpC null mutantaxeA2, axeB2, axeC2, abpC-, abpC(1-739):GFP, bsR
abpC-/[act15]:abpC(149-857):GFPC-terminal fusion of GFP abpC missing the actin binding domain expressed in an abpC null mutantaxeA2, axeB2, axeC2, abpC-, abpC(149-857):GFP, bsR
abpC-/[act15]:abpC:GFPC-terminal fusion of GFP to full length abpC (ABP-120, ddFLN) expressed in an abpC null mutantaxeA2, axeB2, axeC2, abpC-, abpC:GFP, neoR
abpC-/[act15]:GFP:abpC(9-148)N-terminal fusion of GFP to the actin binding domain of abpC (ABP-120, ddFLN) expressed in an abpC null mutantaxeA2, axeB2, axeC2, GFP:abpC(9-148), [pDXA-GABD], neoR
abpC-/[act15]:qkgA(425-1553)N-terminally truncated QkgA with increased basal activity in abpC null mutantaxeA2, axeB2, axeC2, abpA-[pDabgel1.5], qkgA(425-1553), pEXP(+), neoR
abpC-/[cotB]:abpC:GFPC-terminal fusion of GFP to abpC under the control of the prespore cotB promoter expressed in an abpC null mutantaxeA2, axeB2, axeC2, abpC-, [cotB]:abpC:GFP, bsR
abpC-/[ecmA]:abpC:GFPC-terminal fusion of GFP to abpC under the control of the prestalk ecmA promoter expressed in an abpC null mutantaxeA2, axeB2, axeC2, abpC-, [ecmA]:abpC:GFP, bsR
abpD-abpD null mutant; blasticidin resistantaxeA2, axeB2, axeC2, abpD-[abpD-bsr], bsR
abpE-actin binding protein (abpE) null mutantaxeA2, axeB2, axeC2, abpE-[abpE-bsr], bsRaxe, bsR, increased lateral pseudopodia
abpE-abpE null mutant in AX2axeA2, axeB2, axeC2, abpE-, bsR
abpE-/[act15]:abpEabpE null mutant overexpressing abpEaxeA2, axeB2, axeC2, abpE-, abpE+, bsR, neoR
abpG-abpG null mutant in AX2axeA2, axeB2, axeC2, abpG-, [bsRcas], bsR
acaA-ACA-,adenylyl cyclase null (remake of CAP1)axeA1, axeB1, axeC1, acaA-, [pACA.URA], pyr5-6+, [pRG24]axe,agg-
acaA-acaA null in AX2axeA2, axeB2, axeC2, acaA-[BsRCas], bsRaxe, bsR, agg-
acaA-acaA- mutant in JH10 obtained by targeted disruption of the acaA gene.axeA1, axeB1, axeC1, pyr5-6-[PYR5-6-SalI-linker], thy-[PYR5-6-THY1], ura+, acaA-[ACA-thy], thy+axe, agg-
acaA-acaA- mutant obtained in screen of AX4 cells mutagenized by remi using pBSR1 and DpnII.axaA1, axeB1, axeC1, acaA-[pBSR1], bsRaxe, bsR, agg-
acaA-acaA null mutant in Ax4axeA1, axeB1, axeC1, acaA-, [bsRcas], bsR
acaA-Homologous-recombination insertional knockoutaxeA1, axeB1, axeC1, acaA-, [pACA-KO], bsR
acaA-/acgA-/acrA-Homologous-recombination insertional knockoutaxeA1, axeB1, axeC1, acaA-, [pACA-KO], acgA-, [pACG-KO], acrA-, [pACR-KO], bsR
acaA-/acgA-/acrA-/[act15]:pkaC:HApkaC overexpression under control of act15 promoter in adenylate-cyclase triple-nullaxeA1, axeB1, axeC1, acaA-, acgA-, acrA-, [act15]:pkaC:HA, bsR, neoR
acaA-/acgA-/acrA-/[act15]:pkaC:HA/[act15]:GFPpkaC overexpression under control of act15 promoter and GFP-Lifeact, actin structure modified GFP, under control of act15 promoter in adenylate-cyclase triple-nullaxeA1, axeB1, axeC1, acaA-, acgA-, acrA-, [act15]:pkaC:HA, [act15]:GFP, bsR, neoR, hygR
acaA-/acgA-/acrA-/[act15]:pkaC:HA/[act15]:raf-RBD:GFPpkaC overexpression under control of act15 promoter and raf-like ras binding domain (raf_RBD-GFP) under control of act15 promoter in adenylate-cyclase triple-nullaxeA1, axeB1, axeC1, acaA-, acgA-, acrA-, [act15]:pkaC:HA, [act15]:raf-RBD:GFP, bsR, neoR, hygR
acaA-/acgA-/acrA-/[act15]:pkaC:HA/[act15]:RFP:H2Bv3pkaC overexpression under control of act15 promoter and RFP-H2Bv3 (mCherry) under control of act15 promoter in adenylate-cyclase triple-null axeA1, axeB1, axeC1, acaA-, acgA-, acrA-, [act15]:pkaC:HA, [act15]:RFP:2HBv3, bsR, neoR
acaA-/[acaA-agg]:acaA:mycmyc tagged acaA expressed under control of acaA Pr1 (aggregation specific) promotor in acaA null cellsaxeA1, axeB1, axeC1, acaA-, acaA, [bsRcas], bsR, neoR
acaA-/[acaA-psp]:acaA:mycmyc tagged acaA expressed under control of acaA Pr2 promotor (active predominately in prespore cells) expressed in acaA null cellsaxeA1, axeB1, axeC1, acaA-, acaA, [bsRcas], bsR, neoR
acaA-/[acaA-pst]:acaA:mycmyc tagged acaA expressed under control of acaA Pr3 promotor (expressed predominately in prestalk tip cells) in acaA null cellsaxeA1, axeB1, axeC1, acaA-, acaA, [bsRcas], bsR, neoR
acaA-/[act15]:acaAACA under control of actin promotor expressed in aaA null cellsaxeA1, axeB1, axeC1, acaA-, [pACA.URA], pyr5-6+, [pRG24], acaA, [pGSP10], neoR
acaA-/[act15]:acaA(1-390;398-1407)ACA with 7 residue deletion in the amino terminal portion of the C1 domain under control of actin promotor expressed in acaA null cellsaxeA1, axeB1, axeC1, acaA-, [pACA.URA], pyr5-6+, [pRG24], acaA(1-390;398-1407), [pCP33], neoR
acaA-/[act15]:acaA(L394T/K482N)ACA with L394T/K482N substitutions under control of actin promotor expressed in acaA null cellsaxeA1, axeB1, axeC1, acaA-, [pACA.URA], pyr5-6+, [pRG24], acaA(L394T/K482N), [pCP33], neoR
acaA-/[act15]:acaA:YFPacaA-YFP 3'''' fusion overexpressed in acaA- cellsaxeA1, axeB1, axeC1, acaA-, [pACA.URA], pyr5-6+, [pRG24], YFP-acaA, neoR
acaA-/[act15]:cap:GFPCAP with C-terminal GFP expressed in acaA nullaxeA2, axeB2, axeC2, acaA-, cap:GFP, [pflCAP-GFP], bsR, neoR
acaA-/[act15]:HA:pkaCacaA null mutant expressing HA tagged PkaCaxeA1, axeB1, axeC1, acaA-, [pACA.URA], pyr5-6+, [pRG24], HA:pkaC, [pDXA-3C], neoR
acaA-/[act15]:HA:pkaC/acrA-acaA/acrA double null mutant expressing HA tagged PkaC acaA-/[act15]:HA:pkaC (DBS0350702) -Genotype: axeA1, axeB1, axeC1, acaA-, [pACA.URA], pyr5-6+, [pRG24], HA:pkaC, [pDXA-3C], acrA-, [pBSR1], bsR, neoR
acaA-/[act15]:pkaC:HAexpressing PkaC under control of act15 promoter in acaA-axeA1, axeB1, axeC1, acaA-/[act15]:pkaC:HA, bsR, neoR
acaA-/[act15]:pkaR(G135E/G261A)expression of PkaR that is unable to bind cAMP in acaA nullaxeA1, axeB1, axeC1, acaA-, [pACA.URA], pyr5-6+, [pRG24], pkaR(G135E/G261A), neoR
acaA-/[unk]:acaA(F306L/S498Gtemperature sensitive mutant of AcaA with F306L/S498G,K504E,E593V,I649T substitutions expressed in acaA null cellsaxeA1, axeB1, axeC1, acaA-, [pACA.URA], pyr5-6+, [pRG24], acaA(F306L/S498G, K504E, E593V, I649T), [pCP33], neoR
acaA-/[unk]:acaA(N333DAcaA with N333D,G633S point mutations expressed in acaA- axeA1, axeB1, axeC1, acaA-, [pACA.URA], pyr5-6+, [pRG24], acaA(N333D, G633S), [pCC33], neoR
acaA-/[unk]:acaA(V427IAcaA with V427I,S642F point mutations expressed in acaA- axeA1, axeB1, axeC1, acaA-, [pACA.URA], pyr5-6+, [pRG24], acaA(V427I, S642F), [pCC33], neoR
acaA-/[unk]:acgAacgA expressed in acaA null mutantaxeA1, axeB1, axeC1, acaA-, [pACA.URA], pyr5-6+, [pRG24], acgA, neoR
acaA-/[unk]:gcA(E440K/S502Q/H504D)gca with E440K/S502Q/H504D substitutions which change catalytic activity to adenylyl cyclase, expressed in acaA nullaxeA1, axeB1, axeC1, acaA-, [pACA.URA], pyr5-6+, [pRG24], gcA(E440K/S502Q/H504D), [pMB12N], bsR
acapA-acapA null mutant expressed in DH1-10 cellsaxeA1, axeB1, axeC1, pyr5-6- [pRG24], ura-, [bsr-acapA], acapA-, bsR
acapA-acapA null mutantaxeA2, axeB2, axeC2, acapA-, [bsR-loxP], bsR
acapA-/acapB-acapA/acapB double null mutantaxeA2, axeB2, axeC2, acapA-, [bsR-loxP], acapB-, [loxP]
acapA-/[act15]:acapA(R633Q):GFPaxeA1, axeB1, axeC1, pyr5-6- [pRG24], ura-, [bsr-acapA], acapA-, [act15]:acapA(R633Q):GFP, bsR, neomycin
acapA-/[act15]:acapA:GFPGFP tagged AcapA under control of the act15 promotor over-expressed in acapA null cellsaxeA1, axeB1, axeC1, pyr5-6- [pRG24], ura-, [bsr-acapA], acapA-, [pDXA-3C]acapA, bsR, neoR
acapB-acapB null mutantaxeA2, axeB2, axeC2, acapB-, [bsR-loxP], bsR
acbA-acbA null mutantaxeA1, axeB1, axeC1, acbA-[acbA-bsr], bsRaxe,bsR,poor spore vaibility
acbA-/tagA-acbA-/tagA- double null mutantaxeA1, axeB1, axeC1, acbA-, tagA-, bsR
acbA-/tagA-/[cotB]:lacZacbA-/tagA- double null mutant marked with lacZ under the control of the prespore promoter cotBaxeA1, axeB1, axeC1, acbA-, tagA-, [cotB]:lacZ, bsR, neoR
acbA-/tagA-/[ecmA]:GFPacbA-/tagA- double null mutant marked with GFP under the control of the prestalk promoter ecmAaxeA1, axeB1, axeC1, acbA-, tagA-, [ecmA]:GFP, bsR, neoR
acbA-/tagA-/[ecmB]:lacZacbA-/tagA- double null mutant marked with lacZ under the control of the prestalk promoter ecmBaxeA1, axeB1, axeC1, acbA-, tagA-, [ecmB]:lacZ, bsR, neoR
acbA-/[act15]:acbAacbA overexpressor in acbA null mutantaxea1, axeB1, axeC1, acbA-[acbA-bsr], bsR, [A15::acbA/neo], neoRaxe,bsR,neoR
acbA-/[act15]:acbA(Y72A)AbcA with a Tyr to Ala substitution at position 72 expressed in abcA null cells under control of the actin 15 promotor axeA1, axeB1, axeC1, acbA-[acbA-bsr], act15:acbA(Y72A), [pDNeoII], bsR , neoR
acbA-/[act15]:GFPacbA null mutant marked with GFP under the control of the act15 promoter axeA1, axeB1, axeC1, acbA-, [act15]:GFP, bsR, neoR
acbA-/[act15]:tagA(1-890)acbA null mutant overexpressing the protease domain of tagA under the control of the act15 promoteraxeA1, axeB1, axeC1, acbA-, [act15]:tagA(1-890), bsR, neoR
acbA-/[cotB]:lacZacbA null mutant marked with lacZ under the control of the prespore promoter cotBaxeA1, axeB1, axeC1, acbA-, [cotB]:lacZ, bsR, neoR
acbA-/[ecmA]:GFPacbA null mutant marked with GFP under the control of the prestalk promoter ecmAaxeA1, axeB1, axeC1, acbA-, [ecmA]:GFP, bsR, neoR
acbA-/[ecmB]:lacZacbA- null mutant marked with lacZ under the control of the prestalk promoter ecmBaxeA1, axeB1, axeC1, acbA-, [ecmB]:lacZ, bsR, neoR
acgA-acgA null mutant (probably not real null since acgA is located on duplication).axeA1, axeB1, axeC1, acgA-[acg-KO], bsR
acgA-acgA null mutantaxeA2, axeB2, axeC2, acgA-, bsR
acgA-/acrA-Sequential homologous-recombination insertional knockout mediated by Cre-loxP recombinationaxeA1, axeB1, axeC1, acrA-, [pACR-KO], acgA-, [pACG-, O], bsR
acgA-/[acrA]:lacZacrA promoter driving the expression of lacZ in an acgA null mutantaxeA2, axeB2, axeC2, acgA-, bsR, [acrA]:lacZ, neoR
acgRI4Random integrant of acg-KO plasmidaxeA1, axeB1, axeC1, [acg-KO], bsRaxe,bsR
acrA-acrA null strainaxe, matA1, acrA-, [bsR-loxP], bsR
acrA-acrA null (adenylate cyclase) null mutantaxeA1, axeB1, axeC1, acrA-[pBSR1], bsRaxe, bsR, long stalks, very few spores
acrA-/acgA-acrA/acgA double null mutant in Ax4axeA1, axeB1, axeC1, acrA-, [loxP], acgA-, [bsR-loxP], bsR
acrA-/acgA-/acaA-acrA/acgA/acaA triple null mutant in Ax4axeA1, axeB1, axeC1, acrA-, [loxP], acgA-, [loxP], acaA-, [bsR-loxP], bsR
acrA-/acgA-/acaA-/[act15]:pkaC:mycmyc-tagged pkaC under control of act15 promotor expressed in acrA/acgA/acaA triple null mutantaxeA1, axeB1, axeC1, acrA-, [loxP], acgA-, [loxP], acaA-, [bsR-loxP], pkaC, [pDXA-HC], bsR, neoR
acrA-/[act15]:acaA(L394S)constitutive active AcaA with (L394S) substitution expressed in acrA null cellsaxeA1, axeB1, axeC1, acrA-, [pBSR1], acaA(L394S), pCP105, bsR, neoR
acrA-/[act15]:acgA(1-401)a dominant negative acgA (residues 1-401) expressed in an acrA null mutantaxeA2, axeB2, axeC2, acrA-, bsR, [act15]:acgA(1-401), neoR
acrA-/[act15]:acrA(D1010A)AcrA with point mutation in phosphoryl-accepting residue expressed in acrA null strain; rescues the null phenotypeaxe, matA1, acrA-, bsR, acrA(D1010A), neoR
acrA-/[act15]:acrA(D1174A)AcrA with point mutation in phosphoryl-accepting residue expressed in acrA null strain; rescues the null phenotypeaxe, matA1, acrA-, bsR, acrA(D1174A), neoR
acrA-/[act15]:acrA(N796D/D854A/G856A)AcrA with point mutations in both catalytically active and ATP-binding residues expressed in acrA null strain; rescues the null phenotypeaxe, matA1, acrA-, bsR, acrA(N796D/D854A/G856A), neoR
acrA-/[act15]:acrA:YFPYFP-marked AcrA expressed in acrA null strain; rescues the null phenotypeaxe, matA1, acrA-, bsR, acrA:YFP, neoR
acrA-/[pkaC]:pkaCpkaC overexpressed under control of pkaC promotor in acrA null cellsaxeA1, axeB1, axeC1, acrA, [pBSR1], pkaC, [pK-neo], bsR, neoR
act15]:gpaB(K12A/L19A/I21A)gpaB(K12A/L19A/I21A) expressed in KAX3axeA1, axeB1, axeC1, gpaB(K12A/L19A/I21A), [pDXA-GFP], neoR
act5-/[act5]:RFP/NC4mCherry expressed under the act5 promoter replacing the actin 5 gene in NC4, which has no phenotypic relevance; in comparison to axenic strains growth and development are more robustwt, act5-, RFP, [pDM1514], hygR
Acytostelium anastomosans PP1Type specimen (Landolt #2604).wtwt
Acytostelium ellipticumnatural isolatewtwt
Acytostelium ellipticum AE2 (holotype)natural isolate; available from ATCC (no. 22247).wtwt
Acytostelium irregularosporum TNS-C-0037Natural isolate. ATCC no. 28401wt
Acytostelium leptosomumNatural isolate from Tennessee.wtwt
Acytostelium leptosomum FG12Anatural isolatewtwt
Acytostelium longisorophorum DB10A spp stockNatural isolate from the Great Smoky Mountains National Park. Type specimen (Landolt #1810).wtwt
Acytostelium magnisorum 08ANatural isolate. ATCC no. MYA-3270wtwt
Acytostelium serpentarium SAB3ANatural isolate. ATCC no. MYA-3271wtwt
Acytostelium singulare FD1BNatural isolate. ATCC no. MYA-3272wtwt
Acytostelium sp. BB22AIsolate from Great Smoky Mountains National Park. Landolt # 2608.wtwt
Acytostelium sp. GSE10AIsolate from Great Smoky Mountains National Park. Landolt # 2614.wtwt
Acytostelium subglobosumnatural isolate; a different isolate of that strain is being sequenced, Acytostelium subglobosum LB1wtwt
Acytostelium subglobosum LB1Natural isolate from the Philippines (1970); strain being sequenced by Hideko Urushiharawtwt
adcA-adcA null strainaxeA1, axeB1, axeC1, adcA-, bsR
adcB-adcB null mutant expressed in AX2 cellsaxeA2, axeB2, axeC2, adcB-, [bsRcas], bsR
< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 Next >
Home| Contact dictyBase| SOPs| Site Map  Supported by NIH (NIGMS and NHGRI)